08/06/2025
3:30 PM | Neuronetics (Filer)
| Form 424B5 | |
08/05/2025
6:31 AM | Neuronetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2025
6:10 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2025
11:15 PM | Neuronetics (Filer)
| Form EFFECT | |
07/15/2025
4:00 PM | Neuronetics (Issuer)
Pfanstiel Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2025
4:00 PM | Neuronetics (Issuer)
Pfanstiel Steven (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/15/2025
6:30 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2025
4:05 PM | Neuronetics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/28/2025
6:11 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
4:05 PM | Furlong Stephen (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
11:54 AM | Furlong Stephen (Reporting)
Neuronetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for STIM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Neuronetics and its competitors with MarketBeat's FREE daily newsletter. |
05/06/2025
6:30 AM | Neuronetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2025
6:10 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
3:32 PM | Neuronetics (Filer)
| Form DEF 14A | |
04/10/2025
3:33 PM | Neuronetics (Filer)
| Form DEFA14A | |
03/27/2025
3:35 PM | Neuronetics (Filer)
| Form 8-K/A | |
03/27/2025
3:35 PM | Neuronetics (Filer)
| Form PRE 14A | |
03/27/2025
3:36 PM | Neuronetics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2025
4:24 PM | MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
| Form 4/A | |
03/13/2025
4:28 PM | Furlong Stephen (Reporting)
Neuronetics (Issuer)
| Form 4/A | |
03/13/2025
4:30 PM | Neuronetics (Issuer)
Sullivan Keith J (Reporting)
| Form 4/A | |
03/06/2025
4:00 PM | MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
4:00 PM | Furlong Stephen (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
2:16 PM | Furlong Stephen (Reporting)
Neuronetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
2:27 PM | MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:00 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
4:46 PM | Furlong Stephen (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:48 PM | MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:49 PM | Neuronetics (Issuer)
Sullivan Keith J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
4:21 PM | Neuronetics (Issuer)
Sullivan Keith J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
2:16 PM | Neuronetics (Subject)
Sullivan Keith J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
2:13 PM | MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
2:13 PM | Furlong Stephen (Reporting)
Neuronetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2025
2:08 PM | MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2025
2:17 PM | Furlong Stephen (Reporting)
Neuronetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/10/2025
4:16 PM | Cucuz Sasha (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:18 PM | MUIR GLENN P (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:20 PM | CONLEY SHERYL L (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
2:13 PM | Furlong Stephen (Reporting)
Neuronetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/10/2025
2:16 PM | MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/10/2025
2:17 PM | Neuronetics (Subject)
Sullivan Keith J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Sell this, buy that (Ad) What you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strategy: Sell This, Buy That.
In his newest presentation, Eric reveals 7 new trade ideas—pairing overhyped, vulnerable stocks with lesser-known opportunities showing real upside. These contrarian picks come from the same approach that helped him beat Wall Street legends 10-to-1 in Portfolios with Purpose. Click here to see all 7 trade ideas, including full tickers and analysis—100% free. |
02/10/2025
5:03 AM | Neuronetics (Filer)
| Form 424B5 | |
02/06/2025
4:25 PM | Neuronetics (Filer)
| Form 424B5 | |
02/04/2025
4:00 PM | Neuronetics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/13/2025
7:04 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
4:54 PM | Madryn Asset Management, LP (Reporting)
MADRYN HEALTH ADVISORS GP II, LLC (Reporting)
MADRYN HEALTH ADVISORS II, LP (Reporting)
MADRYN HEALTH PARTNERS II , LP (0002007791) (Reporting)
Madryn Health Partners II, LP (Reporting)
MADRYN SELECT ADVISORS GP, LLC (Reporting)
MADRYN SELECT ADVISORS, LP (Reporting)
Madryn Select Opportunities, LP (Reporting)
Neuronetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/19/2024
4:00 PM | Cucuz Sasha (Reporting)
Neuronetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/19/2024
4:00 PM | Amin Avinash (Reporting)
Neuronetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/17/2024
8:15 PM | Madryn Asset Management, LP (Filed by)
Neuronetics (Subject)
| Form SC 13D | |
12/12/2024
4:00 PM | Furlong Stephen (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:00 PM | MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:00 PM | Neuronetics (Issuer)
Sullivan Keith J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:45 PM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
1:32 PM | Kent Lake PR LLC (Filed by)
Neuronetics (Subject)
| Form SCHEDULE 13G | |
11/14/2024
10:32 AM | Neuronetics (Subject)
Parian Global Management LP (Filed by)
| Form SCHEDULE 13G/A | |
11/14/2024
10:17 AM | Divisadero Street Capital Management, LP (Filed by)
Neuronetics (Subject)
| Form SC 13G/A | |
11/13/2024
5:44 AM | Neuronetics (Filer)
| Form 8-K/A | |
11/12/2024
6:31 AM | Neuronetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
6:01 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:03 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:01 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:18 PM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:20 PM | Neuronetics (Filer)
| Form DEFA14A | |
10/10/2024
4:05 PM | MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
4:05 PM | Furlong Stephen (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
3:30 PM | Neuronetics (Filer)
| Form DEFA14A | |
10/08/2024
2:19 PM | MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
2:20 PM | Furlong Stephen (Reporting)
Neuronetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024
4:06 PM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
7:54 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
7:56 AM | Neuronetics (Filer)
| Form DEFA14A | |
10/04/2024
6:34 AM | Neuronetics (Filer)
| Form DEFM14A | |
09/17/2024
6:32 AM | Neuronetics (Filer)
| Form PREM14A | |
09/13/2024
4:02 PM | CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
4:05 PM | MUIR GLENN P (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
4:15 PM | MUIR GLENN P (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
4:15 PM | MUIR GLENN P (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:13 PM | CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:15 PM | MUIR GLENN P (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
4:15 PM | CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:35 PM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
3:36 PM | Neuronetics (Filer)
| Form DEFA14A | |
08/14/2024
5:17 PM | Archon Capital Management LLC (Filed by)
Neuronetics (Subject)
| Form SC 13G/A | |
08/13/2024
7:56 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
8:00 AM | Neuronetics (Filer)
| Form DEFA14A | |
08/12/2024
4:10 PM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:16 PM | Neuronetics (Filer)
| Form DEFA14A | |
08/12/2024
7:33 AM | Neuronetics (Filer)
| Form DEFA14A | |
08/12/2024
7:32 AM | Neuronetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:30 AM | Neuronetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
